Skip to search
Skip to main content
Back to Search
Start Over
Combining Imatinib-Following-Nilotinib Treatment in First Line Therapy for Chronic Phase Chronic Myeloid Leukemia. Update from the PhilosoPhi34 Study at 24 Months of Follow-up
Authors :
Pioltelli, M Pungolino, E D'Adda, M Elena, C Borin, L Perego, A Malato, S Spina, F Artale, S Carraro, M Orofino, N Anghilieri, M Farina, M Latargia, M Iurlo, A Trojani, A Turrini, M Caramella, M Spedini, P Rossi, G Morra, E Cairoli, R Pioltelli ML Pungolino E D'adda M Elena C Borin LM Perego A Malato S Spina F Artale S Carraro M Orofino N Anghilieri M Farina M Latargia ML Iurlo A Trojani A Turrini M Caramella M Spedini P Rossi G Morra E Cairoli R Pioltelli, M Pungolino, E D'Adda, M Elena, C Borin, L Perego, A Malato, S Spina, F Artale, S Carraro, M Orofino, N Anghilieri, M Farina, M Latargia, M Iurlo, A Trojani, A Turrini, M Caramella, M Spedini, P Rossi, G Morra, E Cairoli, R Pioltelli ML Pungolino E D'adda M Elena C Borin LM Perego A Malato S Spina F Artale S Carraro M Orofino N Anghilieri M Farina M Latargia ML Iurlo A Trojani A Turrini M Caramella M Spedini P Rossi G Morra E Cairoli R
Publication Year :
2018
Details
Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1376713946
Document Type :
Electronic Resource